Brian Francis, MD – from the University of Southern California of Los Angeles and the Doheny Eye Institute was one of the early adopters of the Selective Laser Trabeculoplasty (SLT) technology – a micro-incisional glaucoma surgical procedure.

Lumenis introduces ArrayTM LaserLinkTM a technologically advanced delivery system that significantly enhances standard laser treatment by providing new pattern scanning capabilities to photocoagulation lasers and considerably reducing treatment time. Array offers a range of laser spot sizes from 50µm to 1000µm in single spot mode, 100µm to 500µm in pattern scanning mode.

Eager for hands-on learning with Lumenis’ award-winning, innovative technology? Join us at Brilliance and industry meetings to be part of the conversation.

Lumenis, a leading energy-based medical device company for aesthetic and eyecare applications, announced OptiPLUS: A dual frequency RF energy device.

Steven Vold, MD turns to two in-office solutions from Lumenis to reduce his patients’ dependence on drops and give them back control of their daily life. 

Since the introduction of the first laser photocoagulator to ophthalmology in 1970, Lumenis Vision has focused on providing ophthalmologists with innovative laser therapies to preserve and improve the sight of patients worldwide. Lumenis Vision is renowned for technological breakthroughs ophthalmic lasers and a long list of industry gold standards. Our company pioneered the first argon laser photocoagulator for ophthalmology; the first approved marketer of Nd:YAG photodisruptor lasers; developed and introduced the breakthrough technology of multicolor photocoagulation along with the world’s first Laser Indirect Ophthalmoscope (LIO); developed and brought to market the revolutionary SLT technology for managing POAG, and more.

Lumenis Ltd., the world’s largest energy-based medical device company for surgical, aesthetic, and ophthalmic applications, proudly announces its 50th anniversary, which will be celebrated at the American Academy of Dermatology (AAD) Annual Meeting in Orlando, FL from March 3rd – 7th, 2017.

Hear from two prominent dry eye specialists in the Ultimate Guide to OptiLight for Dry Eye and learn about how they incorporated OptiLight into the practice, access comprehensive information on the history of IPL technology, and gain clear understanding on the unique benefits of OptiLight. The guide includes clinical data on how OptiLight can improve meibomian gland dysfunction through several mechanisms of action, along with pre and post treatment care and quick tips for performing the procedure. This ultimate guide provides scripts for easy ways to talk to patients about OptiLight and valuable recommendations from experts who have leveraged OptiLight to provide a real solution to their patients and elevate their practice success.

Listen to this video as Tomas Nido describes how ever since starting his OptiLIGHT by Lumenis journey, he highlights a notable improvement in his daily routine and emphasizes how OptiLIGHT has made a huge difference on his day-to-day life. OptiLIGHT by Lumenis, a real solution for Dry Eyes!

Hear Jaime Chung and James Deom, OD, discussing the unique benefits of OptiLIGHT. Designed to target the root cause of dry eyes, OptiLIGHT by Lumenis stops the dry eye vicious cycle of inflammation.